Table 5 Univariate and multivariate logistic regression analysis for factors associated with CTCRD after 6 months
Univariate | Multivariate | |||||||
|---|---|---|---|---|---|---|---|---|
P-value | Odds ratio (OR) | 95% C.I. for OR | P-value | Odds ratio (OR) | 95% C.I. for OR | |||
Lower | Upper | Lower | Upper | |||||
Diabetes Mellitus | 0.000 | 6.750 | 2.445 | 18.637 | – | – | – | – |
Trastazumab | 0.006 | 4.241 | 1.500 | 11.989 | – | – | – | – |
Baseline | ||||||||
LVESD > 33 | 0.040 | 2.857 | 1.050 | 7.772 | – | – | – | – |
Diastolic function grade I | 0.070 | 6.815 | 0.853 | 54.461 | – | – | – | – |
EF by M-mode < = 60 | 0.010 | 3.710 | 1.360 | 10.123 | – | – | – | – |
RV S’ < = 13 | 0.073 | 4.098 | 0.878 | 19.123 | – | – | – | – |
GLS % < = -18 | 0.001 | 9.333 | 2.546 | 34.214 | – | – | – | – |
GCS % < = -23.9 | 0.014 | 3.385 | 1.274 | 8.995 | – | – | – | – |
RVGLS % < = -22.6 | 0.018 | 3.172 | 1.214 | 8.288 | – | – | – | – |
RV FWLS % < = -24 | 0.040 | 2.857 | 1.050 | 7.772 | – | – | – | – |
After 3 months | ||||||||
LVESD > 33 | 0.000 | 10.217 | 3.128 | 33.375 | – | – | – | – |
EF M mode < = 58 | 0.000 | 33.889 | 9.408 | 122.069 | – | – | – | – |
EF Simpson’s method < = 55 | 0.000 | 82.500 | 18.904 | 360.046 | – | – | – | – |
GLS % < = -15 | 0.000 | 85.250 | 16.803 | 432.517 | – | – | – | – |
RVGLS % < = -18 | 0.000 | 178.250 | 21.115 | 1504.785 | – | – | – | – |
RV FWLS % < = -19 | 0.000 | 207.000 | 24.136 | 1775.303 | – | – | – | – |
GLS change < = 12.5% | 0.000 | 207.000 | 24.136 | 1775.303 | 0.000 | 198.000 | 23.046 | 1701.117 |
RVGLS change < = 21.74% | 0.000 | 198.000 | 23.046 | 1701.117 | – | – | – | – |
RVFWLS change < = 24% | 0.000 | 207.000 | 24.136 | 1775.303 | – | – | – | – |